0001683168-22-002574.txt : 20220412 0001683168-22-002574.hdr.sgml : 20220412 20220412195428 ACCESSION NUMBER: 0001683168-22-002574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220409 FILED AS OF DATE: 20220412 DATE AS OF CHANGE: 20220412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hart Daniel R CENTRAL INDEX KEY: 0001346342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32839 FILM NUMBER: 22823380 MAIL ADDRESS: STREET 1: 2642 MICHELLE DR., SUITE 200 CITY: TUSTIN STATE: CA ZIP: 62780 FORMER NAME: FORMER CONFORMED NAME: Hart Daniel Ryan DATE OF NAME CHANGE: 20051208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avid Bioservices, Inc. CENTRAL INDEX KEY: 0000704562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953698422 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 2642 MICHELLE DRIVE, SUITE 200 CITY: TUSTIN STATE: CA ZIP: 92780 BUSINESS PHONE: 714.508.6100 MAIL ADDRESS: STREET 1: 2642 MICHELLE DRIVE, SUITE 200 CITY: TUSTIN STATE: CA ZIP: 92780 FORMER COMPANY: FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE CORP/DE/ DATE OF NAME CHANGE: 19970924 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2022-04-09 0 0000704562 Avid Bioservices, Inc. CDMO 0001346342 Hart Daniel R 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780 0 1 0 0 Chief Financial Officer Common Stock, $0.001 par value 2022-04-09 4 M 0 1520 A 29496 D Common Stock, $0.001 par value 2022-04-11 4 S 0 726 18.5621 D 28770 D Restricted Stock Units 2022-04-09 4 M 0 1520 0.0000 D Common Stock 1520 46062 D Each Restricted Stock Unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Represents a weighted average sales price per share. These shares were sold at prices ranging from $18.56 to $18.71. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote. RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. /s/ Daniel R. Hart 2022-04-12